Changeflow GovPing Government General Medline Convenience Kit Syringe Recall, 270,311...
Urgent Enforcement Amended Final

Medline Convenience Kit Syringe Recall, 270,311 Units, Class II

Favicon for changeflow.com FDA Device Recalls (Class II)
Filed
Detected
Email

Summary

Medline Industries initiated a Class II recall of 270,311 convenience kits containing 10mL polycarbonate colored syringes distributed nationwide in the US and internationally. The recall was triggered by unapproved design changes made to the syringes outside of the 510(k) clearance process. Affected customers are being notified to request over-labels and replace the recalled syringe components.

“Customers were instructed to request over-labels to place on affected kits containing recalled syringes instructing them to remove the recalled component and replace with product from their supply.”

FDA , verbatim from source
Published by FDA on accessdata.fda.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

Medline Industries initiated a Class II recall of 270,311 convenience kits containing 10mL polycarbonate colored syringes (catalog numbers DYNJ53744B and DYNJ41792G). The recall was initiated on February 27, 2026, after the firm determined that unapproved design changes were made to the syringes outside of the 510(k) clearance process.

Healthcare providers and facilities that received affected kits should contact Medline to request over-labels, place them on affected kits, remove the recalled syringe components, and replace them with compliant alternatives from their supply. The recall affects products distributed US nationwide and to Canada, Panama, and Barbados.

What to do next

  1. Request over-labels for affected kits
  2. Remove the recalled component
  3. Replace with product from supply

Archived snapshot

Apr 20, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Class 2 Device Recall MEDLINE CONVENIENCE KITS

- Databases

| |

| 510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards |

| CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | |

| New Search | ) |

| | Class 2 Device Recall MEDLINE CONVENIENCE KITS | |

Date Initiated by Firm February 27, 2026
Date Posted April 17, 2026
Recall Status Open , Classified
Recall Number Z-1892-2026
Recall Event ID 98601
Product Classification Hysterectomy kit - Product Code OJF
Product Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes

ENSEMBLE GYNECO SCOPIE-LF DYNJ53744B

LAVH GRH-LF DYNJ41792G |
| Code Information | DYNJ53744B
UDI-DI 10193489761689 (EA) 40193489761680 (CS)
LOT 24ABS765

DYNJ41792G

UDI-DI 10195327547127 (EA) 40195327547128 (CS)
LOT 24ABT556 |
| FEI Number | 1417592 |
| Recalling Firm/
Manufacturer | Medline Industries, LP
3 Lakes Dr
Northfield IL 60093-2753 |
| For Additional Information Contact | Haley Barclay
800-633-5463 |
| Manufacturer Reason
for Recall | Unapproved design changes to the products outside of the 510(k) clearance. |
| FDA Determined
Cause | Component change control |
| Action | On February 27, 2026, the firm began notifying customers via email and first-class mail.

Customers were instructed to request over-labels to place on affected kits containing recalled syringes instructing them to remove the recalled component and replace with product from their supply. |
| Quantity in Commerce | 270,311 total |
| Distribution | Worldwide distribution - US Nationwide and the countries of Canada, Panama, Barbados. |
| Total Product Life Cycle | TPLC Device Report |

| 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.

3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |

Get daily alerts for FDA Device Recalls (Class II)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
February 27th, 2026
Instrument
Enforcement
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1892-2026

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Product recall response Market withdrawal
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Healthcare Product Safety

Get alerts for this source

We'll email you when FDA Device Recalls (Class II) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!